SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-08-000096
Filing Date
2008-02-08
Accepted
2008-02-08 16:48:16
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS, L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 124366
  Complete submission text file 0000898432-08-000096.txt   126660
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Subject) CIK: 0000891504 (see all company filings)

IRS No.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1228
Type: SC 13G/A | Act: 34 | File No.: 005-49101 | Film No.: 08589802
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice